An expert on the intersection of HIV and menopause, Bridgette J. Picou, LVN, ACLPN, The Well Project, explains the importance ...

For centuries, it was believed that tuberculosis spread primarily when a vulnerable person spent hours in a poorly ventilated space with someone who was infectious. But new findings suggest that much ...

The use of mobile health care units that distribute ART and PrEP medications increased uptake among people who inject drugs, ...

The University of KwaZulu-Natal (UKZN) is set to host a crucial engagement session on Friday, April 5, focusing on a ...

Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.

Data from the trial—a collaboration led by Rockefeller, Imperial College London and the University of Oxford (RIO)—was ...

taking ensitrelvir within 72 hours of symptoms is effective at preventing infection and generally well tolerated, according to a study presented at the annual Conference on Retroviruses and ...

Spotlight reports on this and some of the other exciting research on long-acting anti-HIV medicines presented at the Conference on Retroviruses and Opportunistic Infections. Several new ...

The findings were presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 Annual Meeting. Previous research has suggested an increased risk for neuropsychiatric ...

Groundbreaking South African HIV cure trial shows 20% of participants maintaining viral suppression without medication for 18 months, marking a significant milestone in HIV research.

In 2020, the Conference on Retroviruses and Opportunistic Infections (CROI) was the first scientific conference to move from in-person to virtual due to the COVID-19 pandemic. On the fifth anniversary ...